更新于 1月27日

GMP Alliance Lead

7-9萬
  • 上海靜安區(qū)
  • 10年以上
  • 本科
  • 全職
  • 招1人

雇員點評標簽

  • 同事很nice
  • 團隊執(zhí)行強
  • 工作環(huán)境好
  • 人際關系好
  • 氛圍活躍
  • 實力大公司

職位描述

ROLE SUMMARY:

This role reports directly to BU GM. The GMP Alliance Lead will be accountable for delivering the General Medicine Portfolio P&L in Pfizer China, leading General Medicine Portfolio strategy, and fostering business innovation to successfully achieve business outcome including but no limited to revenue, market shar, productivity and IBT objectives, maximize business growth and optimizing business sustainability.

This role will work closely with and manage 3rd party/partners to achieve business outcomes, establishing strategic partnerships and ensuring robust alliance management and strategic execution in core therapeutic areas and overseeing deal implementations to enhance the competitive advantages of Pfizer's General Medicine Portfolio. Develop and promote collaborative innovation projects to explore the brand value of Pfizer products and increase the accessibility of patients.

ROLE RESPONSIBILITIES:

  • Accountable for delivering the General Medicine Portfolio P&L in Pfizer China;
  • Develop portfolio and partner strategies for GMP products of Pfizer China to engage well-matched strategic partners with strong capability & cooperation willingness, and well-orchestrated cross-functional execution excellence;
  • Establishing strategic partnerships with 3rd party/partners to foster business innovation;
  • Build-up systematic performance review mechanism and dashboard tracking to achieve business goals( TTD/TTH/IBT) with well-defined 3M strategy;
  • Achieve business target of established products through cooperating with qualified 3rd party/partners, governing their GTM model via effective collaboration /management process;
  • Lead smooth transition and deal implementation for each CSO deal or cooperation program;
  • Support managing and ensure the supply of established products via cooperating with global and local S&OP team, local DCM team;
  • Cooperate with relevant function teams to build SOP of CSO/license-out model, covering internal evaluation/partner screening/deal negotiation and transition/deal execution /monitoring /termination at company level; build response plan for possible risk;
  • Cooperate with Compliance/Legal/Audit team to build high standard monitoring model for collaboration with partners;
  • Build strong network/relationship with potential external partners and stakeholders, help improve capability of partners;
  • Build established portfolio function team with strong talents and define & develop capabilities of commercial excellence

QUALIFICATIONS AND REQUIREMENTS:

  • Bachelor’s degree in Business, Marketing, Pharmacy, or a related field, MBA is perfectible.
  • Proven experience in portfolio management, strategic planning, and cross-functional team leadership.
  • Able to interact, partner, and provide thought leadership for key stakeholders with comfort and ease.
  • Strong business acumen, strong understanding of the China pharmaceutical industry and market dynamics.
  • Excellent communication, negotiation, leadership, and strong interpersonal and influencing capabilities
  • Ability to manage complex projects and drive them to successful completion.
  • Knowledge of compliance and regulatory requirements in the pharmaceutical industry.
  • Excellent oral and written communications capabilities and presentation and facilitation skills

Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.

Mkt & Sales/Commercial Bus

#LI-PFE

工作地點

中信泰富廣場

職位發(fā)布者

劉一飛/人事經理

剛剛活躍
立即溝通
公司Logo輝瑞投資有限公司公司標簽
輝瑞公司(Pfizer Inc.)創(chuàng)建于1849年,總部位于美國紐約,是一家以科學為基礎的、創(chuàng)新的、以患者為先的生物制藥公司。輝瑞的使命是“為患者帶來改變其生活的突破創(chuàng)新”。在輝瑞,我們通過科學和全球資源為人們提供治療方案,以延長其生命,顯著改善其生活。在醫(yī)療衛(wèi)生產品的探索、研發(fā)和生產過程中,輝瑞始終致力于奉行嚴格的質量、安全和價值標準。我們在全球的產品組合包括創(chuàng)新藥品和疫苗。每天,輝瑞在發(fā)達和新興市場的員工都在推進人類健康,推動疾病的預防、治療和治愈,以應對挑戰(zhàn)我們這個時代的頑疾。輝瑞還與醫(yī)療衛(wèi)生服務方、政府和社區(qū)合作,支持并促進世界各地的人們能夠獲得更為可靠和可承付的醫(yī)療衛(wèi)生服務。這與輝瑞作為一家全球卓越的創(chuàng)新生物制藥公司的責任是一致的。170余年來,輝瑞一直致力于為所有依賴我們的人帶來改變。輝瑞于1989年進入中國市場。扎根中國30余年,輝瑞已成為在華主要的外資制藥公司之一。2021年是輝瑞新征程的開始。迄今已有170余年歷史的輝瑞正在邁入全新時代,成為一家以科學為基礎的、創(chuàng)新的、以患者為先的生物制藥公司。目前輝瑞在中國業(yè)務覆蓋全國300余個城市,累計投資超過15億美元,并設立了1家先進的生產設施,2個研發(fā)中心(分別位于上海張江高科技園區(qū)和武漢光谷),在華有近7,000名員工分布于業(yè)務、研發(fā)和生產等領域。輝瑞在華上市了五大領域的高品質創(chuàng)新產品,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見病等多個領域的處方藥和疫苗,強大完善的產品線旨在滿足生命各階段的健康需求。
公司主頁